Johnson & Johnson (JNJ): Price and Financial Metrics

Johnson & Johnson (JNJ)

Today's Latest Price: $149.18 USD

2.01 (1.37%)

Updated Sep 18 7:00pm

Add JNJ to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 232 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

JNJ Stock Summary

  • Johnson & Johnson's market capitalization of $392,764,606,000 is ahead of 99.77% of US-listed equities.
  • Johnson & Johnson's stock had its IPO on January 1, 1986, making it an older stock than 92.88% of US equities in our set.
  • The volatility of Johnson & Johnson's share price is greater than that of only 0.56% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to JNJ, based on their financial statements, market capitalization, and price volatility, are WMT, TSM, PG, MA, and TSLA.
  • JNJ's SEC filings can be seen here. And to visit Johnson & Johnson's official web site, go to
JNJ Daily Price Range
JNJ 52-Week Price Range

JNJ Stock Price Chart Technical Analysis Charts

JNJ Price/Volume Stats

Current price $149.18 52-week high $157.00
Prev. close $147.17 52-week low $109.16
Day low $146.20 Volume 12,174,044
Day high $149.65 Avg. volume 8,458,481
50-day MA $149.00 Dividend yield 2.71%
200-day MA $144.99 Market Cap 392.76B

Johnson & Johnson (JNJ) Company Bio

Johnson & Johnson researches and develops, manufactures, and sells various products in the health-care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. Some of its well-known brands include Tylenol-fever, Listerine-bad breath, Splenda-no-calorie sweetener, Neutrogena-skin care, Pepcid-heartburn, Zyrtec - allergy, Motrin-ibuprofen, Sudafed-allergy, and plenty more. The company was founded in 1885 and is based in New Brunswick, New Jersey.

JNJ Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$149.18$63.43 -57%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Johnson & Johnson. To summarize, we found that Johnson & Johnson ranked in the 27th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Johnson & Johnson, consider:

  • In the past 5.74 years, Johnson & Johnson has a compound free cash flow growth rate of 0.03%; that's higher than merely 24.14% of free cash flow generating stocks in the Healthcare sector.
  • The business' balance sheet reveals debt to be 7% of the company's capital (with equity being the remaining amount). Approximately just 18.2% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • JNJ's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.02% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

HAPP, XRAY, CPIX, WAT, and HOLX can be thought of as valuation peers to JNJ, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

JNJ Latest News Stream

Event/Time News Detail
Loading, please wait...

JNJ Latest Social Stream

Loading social stream, please wait...

View Full JNJ Social Stream

Latest JNJ News From Around the Web

Below are the latest news stories about Johnson & Johnson that investors may wish to consider to help them evaluate JNJ as an investment opportunity.

Johnson & Johnson (JNJ) CEO Alex Gorsky Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)

Johnson & Johnson (JNJ) Morgan Stanley 18th Annual Global Healthcare Conference Call September 16, 2020 10:15 ET Company Participants Alex Gorsky - Chairman and Chief Executive Officer Conference Call Participants David Lewis - Morgan Stanley Presentation David Lewis I want to welcome to the Morgan Stanley Healthcare Conference 2020. Thanks...

SA Transcripts on Seeking Alpha | September 16, 2020

Johnson & Johnson stock falls Wednesday, still outperforms market

COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson & Johnson JNJ dropped 0.33% to $148.40 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.

Yahoo | September 16, 2020

3 Steady Stocks to Buy in a Highly Volatile Market

These stocks have what you want during turbulent times: solid business models, stable cash flows, and reliable dividends.

Yahoo | September 16, 2020

Compass Pathways Seeks $100 Million IPO For Psilocybin-Based Treatment

Quick Take COMPASS Pathways (CMPS) has filed to raise $100 million in an IPO of its ADSs representing underlying ordinary shares, according to an F-1 registration statement. The firm is developing a drug treatment for treatment-resistant depression [TRD]. CMPS is asking IPO investors to pay an above-the-range price for the...

Donovan Jones on Seeking Alpha | September 15, 2020 | Some back out of J&J Covid-19 vaccine trial in Spain after AstraZeneca scare, lead investigator says

News of serious side effects in one participant of AstraZeneca's Covid-19 vaccine trial led some volunteers in Johnson & Johnson's vaccine trial in Spain to drop out, its lead investigator told Reuters on Tuesday

News24 | September 15, 2020

Read More 'JNJ' Stories Here

JNJ Price Returns

1-mo -1.69%
3-mo 4.73%
6-mo 26.88%
1-year 16.39%
3-year 22.73%
5-year 83.18%
YTD 4.32%
2019 16.22%
2018 -5.13%
2017 24.43%
2016 15.33%
2015 1.14%

JNJ Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full JNJ Dividend History

Continue Researching JNJ

Want to see what other sources are saying about Johnson & Johnson's financials and stock price? Try the links below:

Johnson & Johnson (JNJ) Stock Price | Nasdaq
Johnson & Johnson (JNJ) Stock Quote, History and News - Yahoo Finance
Johnson & Johnson (JNJ) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.5436 seconds.